Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30073903HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073904HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073905HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073906HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS20011817HPVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS44000457HTLV-1ENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS44051779HTLV-1ENSG00000185010.15protein_codingF8NoNo2157P00451
TCGA Plot Options
Drug Information
GeneF8
DrugBank IDDB13133
Drug NameVon Willebrand factor human
Target IDBE0000016
UniProt IDP00451
Regulation Typecarrier
PubMed IDs28379876; 26239086
CitationsBrown R: Recombinant von Willebrand factor for severe gastrointestinal bleeding unresponsive to other treatments in a patient with type 2A von Willebrand disease: a case report. Blood Coagul Fibrinolysis. 2017 Oct;28(7):570-575. doi: 10.1097/MBC.0000000000000632.@@Gill JC, Castaman G, Windyga J, Kouides P, Ragni M, Leebeek FW, Obermann-Slupetzky O, Chapman M, Fritsch S, Pavlova BG, Presch I, Ewenstein B: Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease. Blood. 2015 Oct 22;126(17):2038-46. doi: 10.1182/blood-2015-02-629873. Epub 2015 Aug 3.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBL